866-997-4948(US-Canada Toll Free)

2017-2022 Global and Japan Antianaphylaxis drugs Market Analysis Report

Published By :

Jp Research

Published Date : Aug 2017

Category :

Pharmaceutical

No. of Pages : 122 Pages

The global Antianaphylaxis drugs market is valued at XX million USD in 2016 and is expected to reach XX million USD by the end of 2017, growing at a CAGR of XX% between 2016 and 2022.

Japan plays an important role in global market, with market size of xx million USD in 2016 and will be xx million USD in 2017, with a CAGR of xx%.

This report, with focus on top players in the global and Japan, studies the Antianaphylaxis drugs market's development status and future trend in the global and Japan. It splits Antianaphylaxis drugs market by type and by applications to fully and deeply research and reveal market profile and prospect.

The major players include
Asahi Kasei Pharma Corporation
Astellas Pharama Inc.
AstraZeneca K.K
Bayer Yakuhin, Ltd.
DAIICHI SANKYO COMPANY, LIMITED
Eisai Co., Ltd.
Elmed Eisai Co., Ltd.
Kaken Pharmaceutical Co., Ltd.
Kissei Pharmaceutical Co., Ltd.
Kowa Co., Ltd.
Kyorin Pharmacetical Co.,Ltd
Kyowa Hakko Kirin Co.,Ltd
Meiji Seika Pharma Co., Ltd.
Mylan EPD G.K.
Nichi-iko Pharmaceutical Co.,Ltd
Nippon Shinyaku Co., Ltd.
NIPRO CORPORATION
Novartis Pharma K.K.
OHARA Pharmaceutical Co.,Ltd.
Pfizer Pharmaceuticals Inc.
Sanofi K.K.
Santen Pharmaceutical Co.,Ltd.
SANWA KAGAKU KENKYUSHO CO.,LTD.
Sawai Pharmaceutical Co.,Ltd.
Sun Pharma Japan Limited
TAIHO Pharmaceutical Co.,LTD.
TAKATA SEIYAKU Co., Ltd.
TEIJIN PHARMA LIMITED
Teika Pharmaceutical Co.,Ltd.
Teva Takeda Pharma Ltd.

Geographically, this report splits the Global market into the following regions:
Asia Pacific
Japan
Tokyo
Yokohama
Osaka
Nagoya
Others
China
Korea
India
Others
Europe
France
Germany
United Kingdom
Italy
Russia
Others
North America
United States
Canada
Latin America
Brazil
Mexico
Others
Southeast Asia
Singapore
Malaysia
Vietnam
Myanmar
Thailand
Indonesia
Philippines
Others
Middle East & Africa
Saudi Arabia
Iran
UAE
Turkey
Israel
Egypt
South Africa
Others

On the basis of product, the Antianaphylaxis drugs market is primarily split into
Antianaphylaxis drugs Market, by Antihistamine H1 receptor ant
Chlorpheniramine
Cyproheptadine
Hydroxyzine
Diphenhydramine
Dimenhydrinate
Promethazine
Cetirizine
Loratadine
Desloratadine
Mizolastine
Astemizole
Fexofenadine
Methimidazole
Terfenadine
Mequitazine
Levocabastine
Olopatadine
Ebastine
Clemastine
Epinastine
Azelastine
Triprolidine
Antianaphylaxis drugs Market, by Allergic reaction media block
Ketotifen
Sodium Cromoglycate
Baicalin
Ibudilast
Tranilast
Pemirolast
Amlexanox
Zafirlukast
Tiaramide
Proust
Thenalidine
Thenyldiamine
Bufrolin
Antianaphylaxis drugs Market, by Other Anti-Allergic Agents
Pizotifen
Calcium Gluconate
Calcium Chloride
Dermatophagoides Farinae Injection
Prednisone

Key Applications
Department of respiration
Otolaryngology
Department of dermatology
Pharmacy


Table of Contents



2017-2022 Global and Japan Antianaphylaxis drugs Market Analysis Report

1 Antianaphylaxis drugs Overview

1.1 Product Overview and Scope of Antianaphylaxis drugs

1.2 Global and Japan Antianaphylaxis drugs Market by Applications/End Users

1.2.1 Japan Antianaphylaxis drugs Sales () and Market Share Comparison by Applications (2012-2017)

1.2.1.1 Japan Antianaphylaxis drugs Sales () and Market Share by Applications (2012-2017)

1.2.1.2 Japan Antianaphylaxis drugs Sales Growth Rate (%) by Applications (2012-2017)

1.2.1.3 Market Drivers and Opportunities

1.2.2 Japan Antianaphylaxis drugs Sales () and Market Share Comparison by Applications (2012-2017)

1.2.3 Global Antianaphylaxis drugs Sales by Application (2012-2017)

1.2.3.1 Global Antianaphylaxis drugs Sales () and Market Share by Applications (2012-2017)

1.2.3.2 Global Antianaphylaxis drugs Sales Growth Rate (%) by Applications (2012-2017)

1.2.3.3 Market Drivers and Opportunities

1.2.4 Global Antianaphylaxis drugs Sales () and Market Share Comparison by Applications (2012-2017)

1.2.5 Department of respiration

1.2.6 Otolaryngology

1.2.7 Department of dermatology

1.2.8 Pharmacy

1.3 Global and Japan Market Size (Sales and Revenue) of Antianaphylaxis drugs (2012-2017)

1.3.1 Japan Market Size (Sales and Revenue) of Antianaphylaxis drugs (2012-2017)

1.3.1.1 Japan Antianaphylaxis drugs Sales () and Growth Rate (%) (2012-2017)

1.3.1.2 Japan Antianaphylaxis drugs Revenue (Million USD) and Growth Rate (2012-2017)

1.3.2 Global Market Size (Sales and Revenue) of Antianaphylaxis drugs (2012-2017)

1.3.2.1 Global Antianaphylaxis drugs Sales () and Growth Rate (%) (2012-2017)

1.3.2.2 Global Antianaphylaxis drugs Revenue (Million USD) and Growth Rate (2012-2017)

1.4 Global and Japan Classification of Antianaphylaxis drugs by Antihistamine H1 receptor anta

1.4.1 Japan Antianaphylaxis drugs Sales () and Market Share by Antihistamine H1 receptor anta (2012-2017)

1.4.2 Global Antianaphylaxis drugs Sales () and Market Share by Antihistamine H1 receptor anta (2012-2017)

1.4.3 Japan Antianaphylaxis drugs Revenue (Million USD) and Market Share by Antihistamine H1 receptor anta (2012-2017)

1.4.4 Global Antianaphylaxis drugs Revenue (Million USD) and Market Share by Antihistamine H1 receptor anta (2012-2017)

1.4.5 Japan Antianaphylaxis drugs Price () by Antihistamine H1 receptor anta (2012-2017)

1.4.6 Global Antianaphylaxis drugs Price () by Antihistamine H1 receptor anta (2012-2017)

1.4.7 Japan Antianaphylaxis drugs Sales Growth Rate (%) by Antihistamine H1 receptor anta (2012-2017)

1.4.8 Global Antianaphylaxis drugs Sales Growth Rate (%) by Antihistamine H1 receptor anta (2012-2017)

1.4.9 Chlorpheniramine

1.4.10 Cyproheptadine

1.4.11 Hydroxyzine

1.4.12 Diphenhydramine

1.4.13 Dimenhydrinate

Promethazine

Cetirizine

Loratadine

Desloratadine

Mizolastine

Astemizole

Fexofenadine

Methimidazole

Terfenadine

Mequitazine

Levocabastine

Olopatadine

Ebastine

Clemastine

Epinastine

Azelastine

Triprolidine

1.5 Global and Japan Classification of Antianaphylaxis drugs by Allergic reaction media blocke

1.5.1 Japan Antianaphylaxis drugs Sales () and Market Share by Allergic reaction media blocke (2012-2017)

1.5.2 Global Antianaphylaxis drugs Sales () and Market Share by Allergic reaction media blocke (2012-2017)

1.5.3 Japan Antianaphylaxis drugs Revenue (Million USD) and Market Share by Allergic reaction media blocke (2012-2017)

1.5.4 Global Antianaphylaxis drugs Revenue (Million USD) and Market Share by Allergic reaction media blocke (2012-2017)

1.5.5 Japan Antianaphylaxis drugs Price () by Allergic reaction media blocke (2012-2017)

1.5.6 Global Antianaphylaxis drugs Price () by Allergic reaction media blocke (2012-2017)

1.5.7 Japan Antianaphylaxis drugs Sales Growth Rate (%) by Allergic reaction media blocke (2012-2017)

1.5.8 Global Antianaphylaxis drugs Sales Growth Rate (%) by Allergic reaction media blocke (2012-2017)

1.5.9 Ketotifen

1.5.10 Sodium Cromoglycate

1.5.11 Baicalin

1.5.12 Ibudilast

1.5.13 Tranilast

Pemirolast

Amlexanox

Zafirlukast

Tiaramide

Proust

Thenalidine

Thenyldiamine

Bufrolin

1.6 Global and Japan Classification of Antianaphylaxis drugs by Other Anti-Allergic Agents

1.6.1 Japan Antianaphylaxis drugs Sales () and Market Share by Other Anti-Allergic Agents (2012-2017)

1.6.2 Global Antianaphylaxis drugs Sales () and Market Share by Other Anti-Allergic Agents (2012-2017)

1.6.3 Japan Antianaphylaxis drugs Revenue (Million USD) and Market Share by Other Anti-Allergic Agents (2012-2017)

1.6.4 Global Antianaphylaxis drugs Revenue (Million USD) and Market Share by Other Anti-Allergic Agents (2012-2017)

1.6.5 Japan Antianaphylaxis drugs Price () by Other Anti-Allergic Agents (2012-2017)

1.6.6 Global Antianaphylaxis drugs Price () by Other Anti-Allergic Agents (2012-2017)

1.6.7 Japan Antianaphylaxis drugs Sales Growth Rate (%) by Other Anti-Allergic Agents (2012-2017)

1.6.8 Global Antianaphylaxis drugs Sales Growth Rate (%) by Other Anti-Allergic Agents (2012-2017)

1.6.9 Pizotifen

1.6.10 Calcium Gluconate

1.6.11 Calcium Chloride

1.6.12 Dermatophagoides Farinae Injection

1.6.13 Prednisone



2 Global and Japan Antianaphylaxis drugs Market Competition by Players/Manufacturers

2.1 Japan Antianaphylaxis drugs Market Competition by Players/Manufacturers

2.1.1 Japan Antianaphylaxis drugs Sales and Market Share of Key Players/Manufacturers (2012-2017)

2.1.2 Japan Antianaphylaxis drugs Revenue and Share by Players/Manufacturers (2012-2017)

2.1.3 Japan Antianaphylaxis drugs Average Price () by Players/Manufacturers (2012-2017)

2.1.4 Japan Antianaphylaxis drugs Market Competitive Situation and Trends

2.1.4.1 Japan Antianaphylaxis drugs Market Concentration Rate

2.1.4.2 Japan Antianaphylaxis drugs Market Share of Top 3 and Top 5 Players/Manufacturers

2.1.4.3 Mergers & Acquisitions, Expansion in Japan Market

2.1.5 Japan Players/Manufacturers Antianaphylaxis drugs Manufacturing Base Distribution, Sales Area, Product Types

2.2 Global Antianaphylaxis drugs Market Competition by Players/Manufacturers

2.2.1 Global Antianaphylaxis drugs Sales and Market Share of Key Players/Manufacturers (2012-2017)

2.2.2 Global Antianaphylaxis drugs Revenue and Share by Players/Manufacturers (2012-2017)

2.2.3 Global Antianaphylaxis drugs Average Price () by Players/Manufacturers (2012-2017)

2.2.4 Global Antianaphylaxis drugs Market Competitive Situation and Trends

2.2.4.1 Global Antianaphylaxis drugs Market Concentration Rate

2.2.4.2 Global Antianaphylaxis drugs Market Share of Top 3 and Top 5 Players/Manufacturers

2.2.4.3 Mergers & Acquisitions, Expansion in Global Market

2.2.5 Global Players/Manufacturers Antianaphylaxis drugs Manufacturing Base Distribution, Sales Area, Product Types



3 Global and Japan Antianaphylaxis drugs Sales and Revenue by Regions (2012-2017)

3.1 Asia Pacific Antianaphylaxis drugs Sales and Revenue by Regions (2012-2017)

3.1.1 Japan Antianaphylaxis drugs Sales and Revenue (2012-2017)

3.1.1.1 Japan Antianaphylaxis drugs Sales () and Market Share (2012-2017)

3.1.1.2 Japan Antianaphylaxis drugs Revenue (Million USD) and Market Share (2012-2017)

3.1.1.3 Japan Antianaphylaxis drugs Price ()(2012-2017)

3.1.2 China Antianaphylaxis drugs Sales and Revenue (2012-2017)

3.1.2.1 China Antianaphylaxis drugs Sales () and Market Share (2012-2017)

3.1.2.2 China Antianaphylaxis drugs Revenue (Million USD) and Market Share (2012-2017)

3.1.2.3 China Antianaphylaxis drugs Price ()(2012-2017)

3.1.3 Korea Antianaphylaxis drugs Sales and Revenue (2012-2017)

3.1.3.1 Korea Antianaphylaxis drugs Sales () and Market Share (2012-2017)

3.1.3.2 Korea Antianaphylaxis drugs Revenue (Million USD) and Market Share (2012-2017)

3.1.3.3 Korea Antianaphylaxis drugs Price ()(2012-2017)

3.1.4 India Antianaphylaxis drugs Sales and Revenue (2012-2017)

3.1.4.1 India Antianaphylaxis drugs Sales () and Market Share (2012-2017)

3.1.4.2 India Antianaphylaxis drugs Revenue (Million USD) and Market Share (2012-2017)

3.1.4.3 India Antianaphylaxis drugs Price ()(2012-2017)

3.1.5 Others Antianaphylaxis drugs Sales and Revenue (2012-2017)

3.1.5.1 Others Antianaphylaxis drugs Sales () and Market Share (2012-2017)

3.1.5.2 Others Antianaphylaxis drugs Revenue (Million USD) and Market Share (2012-2017)

3.1.5.3 Others Antianaphylaxis drugs Price ()(2012-2017)

3.2 Europe Antianaphylaxis drugs Sales and Revenue by Regions (2012-2017)

3.2.1 France Antianaphylaxis drugs Sales and Revenue (2012-2017)

3.2.1.1 France Antianaphylaxis drugs Sales () and Market Share (2012-2017)

3.2.1.2 France Antianaphylaxis drugs Revenue (Million USD) and Market Share (2012-2017)

3.2.1.3 France Antianaphylaxis drugs Price ()(2012-2017)

3.2.2 Germany Antianaphylaxis drugs Sales and Revenue (2012-2017)

3.2.2.1 Germany Antianaphylaxis drugs Sales () and Market Share (2012-2017)

3.2.2.2 Germany Antianaphylaxis drugs Revenue (Million USD) and Market Share (2012-2017)

3.2.2.3 Germany Antianaphylaxis drugs Price ()(2012-2017)

3.2.3 United Kingdom Antianaphylaxis drugs Sales and Revenue (2012-2017)

3.2.3.1 United Kingdom Antianaphylaxis drugs Sales () and Market Share (2012-2017)

3.2.3.2 United Kingdom Antianaphylaxis drugs Revenue (Million USD) and Market Share (2012-2017)

3.2.3.3 United Kingdom Antianaphylaxis drugs Price ()(2012-2017)

3.2.4 Italy Antianaphylaxis drugs Sales and Revenue (2012-2017)

3.2.4.1 Italy Antianaphylaxis drugs Sales () and Market Share (2012-2017)

3.2.4.2 Italy Antianaphylaxis drugs Revenue (Million USD) and Market Share (2012-2017)

3.2.4.3 Italy Antianaphylaxis drugs Price ()(2012-2017)

3.2.5 Russia Antianaphylaxis drugs Sales and Revenue (2012-2017)

3.2.5.1 Russia Antianaphylaxis drugs Sales () and Market Share (2012-2017)

3.2.5.2 Russia Antianaphylaxis drugs Revenue (Million USD) and Market Share (2012-2017)

3.2.5.3 Russia Antianaphylaxis drugs Price ()(2012-2017)

3.2.6 Others Antianaphylaxis drugs Sales and Revenue (2012-2017)

3.2.6.1 Others Antianaphylaxis drugs Sales () and Market Share (2012-2017)

3.2.6.2 Others Antianaphylaxis drugs Revenue (Million USD) and Market Share (2012-2017)

3.2.6.3 Others Antianaphylaxis drugs Price ()(2012-2017)

3.3 North America Antianaphylaxis drugs Sales and Revenue by Regions (2012-2017)

3.3.1 United States Antianaphylaxis drugs Sales and Revenue (2012-2017)

3.3.1.1 United States Antianaphylaxis drugs Sales () and Market Share (2012-2017)

3.3.1.2 United States Antianaphylaxis drugs Revenue (Million USD) and Market Share (2012-2017)

3.3.1.3 United States Antianaphylaxis drugs Price ()(2012-2017)

3.3.2 Canada Antianaphylaxis drugs Sales and Revenue (2012-2017)

3.3.2.1 Canada Antianaphylaxis drugs Sales () and Market Share (2012-2017)

3.3.2.2 Canada Antianaphylaxis drugs Revenue (Million USD) and Market Share (2012-2017)

3.3.2.3 Canada Antianaphylaxis drugs Price ()(2012-2017)

3.4 Latin America Antianaphylaxis drugs Sales and Revenue by Regions (2012-2017)

3.4.1 Brazil Antianaphylaxis drugs Sales and Revenue (2012-2017)

3.4.1.1 Brazil Antianaphylaxis drugs Sales () and Market Share (2012-2017)

3.4.1.2 Brazil Antianaphylaxis drugs Revenue (Million USD) and Market Share (2012-2017)

3.4.1.3 Brazil Antianaphylaxis drugs Price ()(2012-2017)

3.4.2 Mexico Antianaphylaxis drugs Sales and Revenue (2012-2017)

3.4.2.1 Mexico Antianaphylaxis drugs Sales () and Market Share (2012-2017)

3.4.2.2 Mexico Antianaphylaxis drugs Revenue (Million USD) and Market Share (2012-2017)

3.4.2.3 Mexico Antianaphylaxis drugs Price ()(2012-2017)

3.4.3 Others Antianaphylaxis drugs Sales and Revenue (2012-2017)

3.4.3.1 Others Antianaphylaxis drugs Sales () and Market Share (2012-2017)

3.4.3.2 Others Antianaphylaxis drugs Revenue (Million USD) and Market Share (2012-2017)

3.4.3.3 Others Antianaphylaxis drugs Price ()(2012-2017)

3.5 Southeast Asia Antianaphylaxis drugs Sales and Revenue by Regions (2012-2017)

3.5.1 Singapore Antianaphylaxis drugs Sales and Revenue (2012-2017)

3.5.1.1 Singapore Antianaphylaxis drugs Sales () and Market Share (2012-2017)

3.5.1.2 Singapore Antianaphylaxis drugs Revenue (Million USD) and Market Share (2012-2017)

3.5.1.3 Singapore Antianaphylaxis drugs Price ()(2012-2017)

3.5.2 Malaysia Antianaphylaxis drugs Sales and Revenue (2012-2017)

3.5.2.1 Malaysia Antianaphylaxis drugs Sales () and Market Share (2012-2017)

3.5.2.2 Malaysia Antianaphylaxis drugs Revenue (Million USD) and Market Share (2012-2017)

3.5.2.3 Malaysia Antianaphylaxis drugs Price ()(2012-2017)

3.5.3 Vietnam Antianaphylaxis drugs Sales and Revenue (2012-2017)

3.5.3.1 Vietnam Antianaphylaxis drugs Sales () and Market Share (2012-2017)

3.5.3.2 Vietnam Antianaphylaxis drugs Revenue (Million USD) and Market Share (2012-2017)

3.5.3.3 Vietnam Antianaphylaxis drugs Price ()(2012-2017)

3.5.4 Myanmar Antianaphylaxis drugs Sales and Revenue (2012-2017)

3.5.4.1 Myanmar Antianaphylaxis drugs Sales () and Market Share (2012-2017)

3.5.4.2 Myanmar Antianaphylaxis drugs Revenue (Million USD) and Market Share (2012-2017)

3.5.4.3 Myanmar Antianaphylaxis drugs Price ()(2012-2017)

3.5.5 Thailand Antianaphylaxis drugs Sales and Revenue (2012-2017)

3.5.5.1 Thailand Antianaphylaxis drugs Sales () and Market Share (2012-2017)

3.5.5.2 Thailand Antianaphylaxis drugs Revenue (Million USD) and Market Share (2012-2017)

3.5.5.3 Thailand Antianaphylaxis drugs Price ()(2012-2017)

3.5.6 Indonesia Antianaphylaxis drugs Sales and Revenue (2012-2017)

3.5.6.1 Indonesia Antianaphylaxis drugs Sales () and Market Share (2012-2017)

3.5.6.2 Indonesia Antianaphylaxis drugs Revenue (Million USD) and Market Share (2012-2017)

3.5.6.3 Indonesia Antianaphylaxis drugs Price ()(2012-2017)

3.5.7 Philippines Antianaphylaxis drugs Sales and Revenue (2012-2017)

3.5.7.1 Philippines Antianaphylaxis drugs Sales () and Market Share (2012-2017)

3.5.7.2 Philippines Antianaphylaxis drugs Revenue (Million USD) and Market Share (2012-2017)

3.5.7.3 Philippines Antianaphylaxis drugs Price ()(2012-2017)

3.5.8 Others Antianaphylaxis drugs Sales and Revenue (2012-2017)

3.5.8.1 Others Antianaphylaxis drugs Sales () and Market Share (2012-2017)

3.5.8.2 Others Antianaphylaxis drugs Revenue (Million USD) and Market Share (2012-2017)

3.5.8.3 Others Antianaphylaxis drugs Price ()(2012-2017)

3.6 Middle East & Africa Antianaphylaxis drugs Sales and Revenue by Regions (2012-2017)

3.6.1 Saudi Arabia Antianaphylaxis drugs Sales and Revenue (2012-2017)

3.6.1.1 Saudi Arabia Antianaphylaxis drugs Sales () and Market Share (2012-2017)

3.6.1.2 Saudi Arabia Antianaphylaxis drugs Revenue (Million USD) and Market Share (2012-2017)

3.6.1.3 Saudi Arabia Antianaphylaxis drugs Price ()(2012-2017)

3.6.2 Iran Antianaphylaxis drugs Sales and Revenue (2012-2017)

3.6.2.1 Iran Antianaphylaxis drugs Sales () and Market Share (2012-2017)

3.6.2.2 Iran Antianaphylaxis drugs Revenue (Million USD) and Market Share (2012-2017)

3.6.2.3 Iran Antianaphylaxis drugs Price ()(2012-2017)

3.6.3 UAE Antianaphylaxis drugs Sales and Revenue (2012-2017)

3.6.3.1 UAE Antianaphylaxis drugs Sales () and Market Share (2012-2017)

3.6.3.2 UAE Antianaphylaxis drugs Revenue (Million USD) and Market Share (2012-2017)

3.6.3.3 UAE Antianaphylaxis drugs Price ()(2012-2017)

3.6.4 Turkey Antianaphylaxis drugs Sales and Revenue (2012-2017)

3.6.4.1 Turkey Antianaphylaxis drugs Sales () and Market Share (2012-2017)

3.6.4.2 Turkey Antianaphylaxis drugs Revenue (Million USD) and Market Share (2012-2017)

3.6.4.3 Turkey Antianaphylaxis drugs Price ()(2012-2017)

3.6.5 Israel Antianaphylaxis drugs Sales and Revenue (2012-2017)

3.6.5.1 Israel Antianaphylaxis drugs Sales () and Market Share (2012-2017)

3.6.5.2 Israel Antianaphylaxis drugs Revenue (Million USD) and Market Share (2012-2017)

3.6.5.3 Israel Antianaphylaxis drugs Price ()(2012-2017)

3.6.6 Egypt Antianaphylaxis drugs Sales and Revenue (2012-2017)

3.6.6.1 Egypt Antianaphylaxis drugs Sales () and Market Share (2012-2017)

3.6.6.2 Egypt Antianaphylaxis drugs Revenue (Million USD) and Market Share (2012-2017)

3.6.6.3 Egypt Antianaphylaxis drugs Price ()(2012-2017)

3.6.7 South Africa Antianaphylaxis drugs Sales and Revenue (2012-2017)

3.6.7.1 South Africa Antianaphylaxis drugs Sales () and Market Share (2012-2017)

3.6.7.2 South Africa Antianaphylaxis drugs Revenue (Million USD) and Market Share (2012-2017)

3.6.7.3 South Africa Antianaphylaxis drugs Price ()(2012-2017)

3.6.8 Others Antianaphylaxis drugs Sales and Revenue (2012-2017)

3.6.8.1 Others Antianaphylaxis drugs Sales () and Market Share (2012-2017)

3.6.8.2 Others Antianaphylaxis drugs Revenue (Million USD) and Market Share (2012-2017)

3.6.8.3 Others Antianaphylaxis drugs Price ()(2012-2017)



4 Global and Japan Antianaphylaxis drugs Players/Manufacturers Profiles and Sales Data

4.1 Asahi Kasei Pharma Corporation

4.1.1 Company Basic Information, Manufacturing Base and Competitors

4.1.2 Antianaphylaxis drugs Product Category, Application and Specification

4.1.2.1 Product A

4.1.2.2 Product B

4.1.3 Asahi Kasei Pharma Corporation Antianaphylaxis drugs Sales (), Revenue (Million USD), Price () and Gross Margin (%)(2012-2017)

4.1.4 Main Business/Business Overview

4.2 Astellas Pharama Inc.

4.2.1 Company Basic Information, Manufacturing Base and Competitors

4.2.2 Antianaphylaxis drugs Product Category, Application and Specification

4.2.2.1 Product A

4.2.2.2 Product B

4.2.3 Astellas Pharama Inc. Antianaphylaxis drugs Sales (), Revenue (Million USD), Price () and Gross Margin (%)(2012-2017)

4.2.4 Main Business/Business Overview

4.3 AstraZeneca K.K

4.3.1 Company Basic Information, Manufacturing Base and Competitors

4.3.2 Antianaphylaxis drugs Product Category, Application and Specification

4.3.2.1 Product A

4.3.2.2 Product B

4.3.3 AstraZeneca K.K Antianaphylaxis drugs Sales (), Revenue (Million USD), Price () and Gross Margin (%)(2012-2017)

4.3.4 Main Business/Business Overview

4.4 Bayer Yakuhin, Ltd.

4.4.1 Company Basic Information, Manufacturing Base and Competitors

4.4.2 Antianaphylaxis drugs Product Category, Application and Specification

4.4.2.1 Product A

4.4.2.2 Product B

4.4.3 Bayer Yakuhin, Ltd. Antianaphylaxis drugs Sales (), Revenue (Million USD), Price () and Gross Margin (%)(2012-2017)

4.4.4 Main Business/Business Overview

4.5 DAIICHI SANKYO COMPANY, LIMITED

4.5.1 Company Basic Information, Manufacturing Base and Competitors

4.5.2 Antianaphylaxis drugs Product Category, Application and Specification

4.5.2.1 Product A

4.5.2.2 Product B

4.5.3 DAIICHI SANKYO COMPANY, LIMITED Antianaphylaxis drugs Sales (), Revenue (Million USD), Price () and Gross Margin (%)(2012-2017)

4.5.4 Main Business/Business Overview

4.6 Eisai Co., Ltd.

4.6.1 Company Basic Information, Manufacturing Base and Competitors

4.6.2 Antianaphylaxis drugs Product Category, Application and Specification

4.6.2.1 Product A

4.6.2.2 Product B

4.6.3 Eisai Co., Ltd. Antianaphylaxis drugs Sales (), Revenue (Million USD), Price () and Gross Margin (%)(2012-2017)

4.6.4 Main Business/Business Overview

4.7 Elmed Eisai Co., Ltd.

4.7.1 Company Basic Information, Manufacturing Base and Competitors

4.7.2 Antianaphylaxis drugs Product Category, Application and Specification

4.7.2.1 Product A

4.7.2.2 Product B

4.7.3 Elmed Eisai Co., Ltd. Antianaphylaxis drugs Sales (), Revenue (Million USD), Price () and Gross Margin (%)(2012-2017)

4.7.4 Main Business/Business Overview

4.8 Kaken Pharmaceutical Co., Ltd.

4.8.1 Company Basic Information, Manufacturing Base and Competitors

4.8.2 Antianaphylaxis drugs Product Category, Application and Specification

4.8.2.1 Product A

4.8.2.2 Product B

4.8.3 Kaken Pharmaceutical Co., Ltd. Antianaphylaxis drugs Sales (), Revenue (Million USD), Price () and Gross Margin (%)(2012-2017)

4.8.4 Main Business/Business Overview

4.9 Kissei Pharmaceutical Co., Ltd.

4.9.1 Company Basic Information, Manufacturing Base and Competitors

4.9.2 Antianaphylaxis drugs Product Category, Application and Specification

4.9.2.1 Product A

4.9.2.2 Product B

4.9.3 Kissei Pharmaceutical Co., Ltd. Antianaphylaxis drugs Sales (), Revenue (Million USD), Price () and Gross Margin (%)(2012-2017)

4.9.4 Main Business/Business Overview

4.10 Kowa Co., Ltd.

4.10.1 Company Basic Information, Manufacturing Base and Competitors

4.10.2 Antianaphylaxis drugs Product Category, Application and Specification

4.10.2.1 Product A

4.10.2.2 Product B

4.10.3 Kowa Co., Ltd. Antianaphylaxis drugs Sales (), Revenue (Million USD), Price () and Gross Margin (%)(2012-2017)

4.10.4 Main Business/Business Overview

4.11 Kyorin Pharmacetical Co.,Ltd

4.12 Kyowa Hakko Kirin Co.,Ltd

4.13 Meiji Seika Pharma Co., Ltd.

4.14 Mylan EPD G.K.

4.15 Nichi-iko Pharmaceutical Co.,Ltd

4.16 Nippon Shinyaku Co., Ltd.

4.17 NIPRO CORPORATION

4.18 Novartis Pharma K.K.

4.19 OHARA Pharmaceutical Co.,Ltd.

4.20 Pfizer Pharmaceuticals Inc.

4.21 Sanofi K.K.

4.22 Santen Pharmaceutical Co.,Ltd.

4.23 SANWA KAGAKU KENKYUSHO CO.,LTD.

4.24 Sawai Pharmaceutical Co.,Ltd.

4.25 Sun Pharma Japan Limited

4.26 TAIHO Pharmaceutical Co.,LTD.

4.27 TAKATA SEIYAKU Co., Ltd.

4.28 TEIJIN PHARMA LIMITED

4.29 Teika Pharmaceutical Co.,Ltd.

4.30 Teva Takeda Pharma Ltd.



5 Antianaphylaxis drugs Manufacturing Cost Analysis

5.1 Antianaphylaxis drugs Key Raw Materials Analysis

5.1.1 Key Raw Materials

5.1.2 Price Trend of Key Raw Materials

5.1.3 Key Suppliers of Raw Materials

5.1.4 Market Concentration Rate of Raw Materials

5.2 Proportion of Manufacturing Cost Structure

5.2.1 Raw Materials

5.2.2 Labor Cost

5.2.3 Manufacturing Expenses

5.3 Manufacturing Process Analysis of Antianaphylaxis drugs



6 Industrial Chain, Sourcing Strategy and Downstream Buyers

6.1 Antianaphylaxis drugs Industrial Chain Analysis

6.2 Upstream Raw Materials Sourcing

6.3 Raw Materials Sources of Antianaphylaxis drugs Major Players/Manufacturers in 2016

6.4 Downstream Buyers



7 Marketing Strategy Analysis, Distributors/Traders

7.1 Marketing Channel

7.1.1 Direct Marketing

7.1.2 Indirect Marketing

7.1.3 Marketing Channel Development Trend

7.2 Market Positioning

7.2.1 Pricing Strategy

7.2.2 Brand Strategy

7.2.3 Target Client

7.3 Distributors/Traders List



8 Market Effect Factors Analysis

8.1 Technology Progress/Risk

8.1.1 Substitutes Threat

8.1.2 Technology Progress in Related Industry

8.2 Consumer Needs/Customer Preference Change

8.3 Economic/Political Environmental Change



9 Global and Japan Antianaphylaxis drugs Market Size (Sales and Revenue) Forecast (2017-2022)

9.1 Global and Japan Antianaphylaxis drugs Sales (), Revenue (Million USD) Forecast (2017-2022)

9.2 Global and Japan Antianaphylaxis drugs Sales () Forecast by Type (2017-2022)

9.2.1 by Antihistamine H1 receptor anta

9.2.2 by Allergic reaction media blocke

9.2.3 by Other Anti-Allergic Agents

9.3 Global and Japan Antianaphylaxis drugs Sales () Forecast by Application (2017-2022)

9.4 Global and Japan Antianaphylaxis drugs Sales () Forecast by Regions (2017-2022)



10 Research Findings and Conclusion



11 Methodology and Data Source

11.1 Methodology/Research Approach

11.1.1 Research Programs/Design

11.1.2 Market Size Estimation

11.1.3 Market Breakdown and Data Triangulation

11.2 Data Source

11.2.1 Secondary Sources

11.2.2 Primary Sources

11.3 Disclaimer

11.4 Author List





List of Table

List of Tables and Figures



Figure Product Picture of Antianaphylaxis drugs

Table Japan Antianaphylaxis drugs Sales (Million Units) Comparison by Applications (2012-2017)

Figure Japan Sales Market Share (%) of Antianaphylaxis drugs by Applications in 2016

Table Global Antianaphylaxis drugs Sales (Million Units) Comparison by Applications (2012-2017)

Figure Global Sales Market Share (%) of Antianaphylaxis drugs by Applications in 2016

Figure Department of respiration Examples

Table Key Downstream Customer in Department of respiration

Figure Otolaryngology Examples

Table Key Downstream Customer in Otolaryngology

Figure Department of dermatology Examples

Table Key Downstream Customer in Department of dermatology

Figure Pharmacy Examples

Table Key Downstream Customer in Pharmacy

Figure Chlorpheniramine Product Picture

Figure Cyproheptadine Product Picture

Figure Hydroxyzine Product Picture

Figure Diphenhydramine Product Picture

Figure Dimenhydrinate Product Picture

Figure Ketotifen Product Picture

Figure Sodium Cromoglycate Product Picture

Figure Baicalin Product Picture

Figure Ibudilast Product Picture

Figure Tranilast Product Picture

Figure Pizotifen Product Picture

Figure Calcium Gluconate Product Picture

Figure Calcium Chloride Product Picture

Figure Dermatophagoides Farinae Injection Product Picture

Figure Prednisone Product Picture

Table Asahi Kasei Pharma Corporation Basic Information List

Table Asahi Kasei Pharma Corporation Antianaphylaxis drugs Sales (), Revenue (Million USD), Price () and Gross Margin (%)(2012-2017)

Table Asahi Kasei Pharma Corporation Antianaphylaxis drugs Sales Growth Rate (%)(2012-2017)

Table Asahi Kasei Pharma Corporation Antianaphylaxis drugs Sales Market Share (%) in Japan (2012-2017)

Figure Asahi Kasei Pharma Corporation Antianaphylaxis drugs Revenue Market Share (%) in Japan (2012-2017)

Table Astellas Pharama Inc. Basic Information List

Table Astellas Pharama Inc. Antianaphylaxis drugs Sales (), Revenue (Million USD), Price () and Gross Margin (%)(2012-2017)

Table Astellas Pharama Inc. Antianaphylaxis drugs Sales Growth Rate (%)(2012-2017)

Table Astellas Pharama Inc. Antianaphylaxis drugs Sales Market Share (%) in Japan (2012-2017)

Figure Astellas Pharama Inc. Antianaphylaxis drugs Revenue Market Share (%) in Japan (2012-2017)

Table AstraZeneca K.K Basic Information List

Table AstraZeneca K.K Antianaphylaxis drugs Sales (), Revenue (Million USD), Price () and Gross Margin (%)(2012-2017)

Table AstraZeneca K.K Antianaphylaxis drugs Sales Growth Rate (%)(2012-2017)

Table AstraZeneca K.K Antianaphylaxis drugs Sales Market Share (%) in Japan (2012-2017)

Figure AstraZeneca K.K Antianaphylaxis drugs Revenue Market Share (%) in Japan (2012-2017)

Table Bayer Yakuhin, Ltd. Basic Information List

Table Bayer Yakuhin, Ltd. Antianaphylaxis drugs Sales (), Revenue (Million USD), Price () and Gross Margin (%)(2012-2017)

Table Bayer Yakuhin, Ltd. Antianaphylaxis drugs Sales Growth Rate (%)(2012-2017)

Table Bayer Yakuhin, Ltd. Antianaphylaxis drugs Sales Market Share (%) in Japan (2012-2017)

Figure Bayer Yakuhin, Ltd. Antianaphylaxis drugs Revenue Market Share (%) in Japan (2012-2017)

Table DAIICHI SANKYO COMPANY, LIMITED Basic Information List

Table DAIICHI SANKYO COMPANY, LIMITED Antianaphylaxis drugs Sales (), Revenue (Million USD), Price () and Gross Margin (%)(2012-2017)

Table DAIICHI SANKYO COMPANY, LIMITED Antianaphylaxis drugs Sales Growth Rate (%)(2012-2017)

Table DAIICHI SANKYO COMPANY, LIMITED Antianaphylaxis drugs Sales Market Share (%) in Japan (2012-2017)

Figure DAIICHI SANKYO COMPANY, LIMITED Antianaphylaxis drugs Revenue Market Share (%) in Japan (2012-2017)

Table Eisai Co., Ltd. Basic Information List

Table Eisai Co., Ltd. Antianaphylaxis drugs Sales (), Revenue (Million USD), Price () and Gross Margin (%)(2012-2017)

Table Eisai Co., Ltd. Antianaphylaxis drugs Sales Growth Rate (%)(2012-2017)

Table Eisai Co., Ltd. Antianaphylaxis drugs Sales Market Share (%) in Japan (2012-2017)

Figure Eisai Co., Ltd. Antianaphylaxis drugs Revenue Market Share (%) in Japan (2012-2017)

Table Elmed Eisai Co., Ltd. Basic Information List

Table Elmed Eisai Co., Ltd. Antianaphylaxis drugs Sales (), Revenue (Million USD), Price () and Gross Margin (%)(2012-2017)

Table Elmed Eisai Co., Ltd. Antianaphylaxis drugs Sales Growth Rate (%)(2012-2017)

Table Elmed Eisai Co., Ltd. Antianaphylaxis drugs Sales Market Share (%) in Japan (2012-2017)

Figure Elmed Eisai Co., Ltd. Antianaphylaxis drugs Revenue Market Share (%) in Japan (2012-2017)

Table Kaken Pharmaceutical Co., Ltd. Basic Information List

Table Kaken Pharmaceutical Co., Ltd. Antianaphylaxis drugs Sales (), Revenue (Million USD), Price () and Gross Margin (%)(2012-2017)

Table Kaken Pharmaceutical Co., Ltd. Antianaphylaxis drugs Sales Growth Rate (%)(2012-2017)

Table Kaken Pharmaceutical Co., Ltd. Antianaphylaxis drugs Sales Market Share (%) in Japan (2012-2017)

Figure Kaken Pharmaceutical Co., Ltd. Antianaphylaxis drugs Revenue Market Share (%) in Japan (2012-2017)

Table Kissei Pharmaceutical Co., Ltd. Basic Information List

Table Kissei Pharmaceutical Co., Ltd. Antianaphylaxis drugs Sales (), Revenue (Million USD), Price () and Gross Margin (%)(2012-2017)

Table Kissei Pharmaceutical Co., Ltd. Antianaphylaxis drugs Sales Growth Rate (%)(2012-2017)

Table Kissei Pharmaceutical Co., Ltd. Antianaphylaxis drugs Sales Market Share (%) in Japan (2012-2017)

Figure Kissei Pharmaceutical Co., Ltd. Antianaphylaxis drugs Revenue Market Share (%) in Japan (2012-2017)

Table Kowa Co., Ltd. Basic Information List

Table Kowa Co., Ltd. Antianaphylaxis drugs Sales (), Revenue (Million USD), Price () and Gross Margin (%)(2012-2017)

Table Kowa Co., Ltd. Antianaphylaxis drugs Sales Growth Rate (%)(2012-2017)

Table Kowa Co., Ltd. Antianaphylaxis drugs Sales Market Share (%) in Japan (2012-2017)

Figure Kowa Co., Ltd. Antianaphylaxis drugs Revenue Market Share (%) in Japan (2012-2017)

Table Kyorin Pharmacetical Co.,Ltd Basic Information List

Table Kyowa Hakko Kirin Co.,Ltd Basic Information List

Table Meiji Seika Pharma Co., Ltd. Basic Information List

Table Mylan EPD G.K. Basic Information List

Table Nichi-iko Pharmaceutical Co.,Ltd Basic Information List

Table Nippon Shinyaku Co., Ltd. Basic Information List

Table NIPRO CORPORATION Basic Information List

Table Novartis Pharma K.K. Basic Information List

Table OHARA Pharmaceutical Co.,Ltd. Basic Information List

Table Pfizer Pharmaceuticals Inc. Basic Information List

Table Sanofi K.K. Basic Information List

Table Santen Pharmaceutical Co.,Ltd. Basic Information List

Table SANWA KAGAKU KENKYUSHO CO.,LTD. Basic Information List

Table Sawai Pharmaceutical Co.,Ltd. Basic Information List

Table Sun Pharma Japan Limited Basic Information List

Table TAIHO Pharmaceutical Co.,LTD. Basic Information List

Table TAKATA SEIYAKU Co., Ltd. Basic Information List

Table TEIJIN PHARMA LIMITED Basic Information List

Table Teika Pharmaceutical Co.,Ltd. Basic Information List

Table Teva Takeda Pharma Ltd. Basic Information List

Table Production Base and Market Concentration Rate of Raw Material

Figure Price Trend of Key Raw Materials

Table Key Suppliers of Raw Materials

Figure Manufacturing Cost Structure of Antianaphylaxis drugs

Figure Manufacturing Process Analysis of Antianaphylaxis drugs

Figure Antianaphylaxis drugs Industrial Chain Analysis

Table Raw Materials Sources of Antianaphylaxis drugs Major Players/Manufacturers in 2016

Table Major Buyers of Antianaphylaxis drugs

Table Distributors/Traders List

Figure Japan Antianaphylaxis drugs Sales () and Growth Rate (%) Forecast (2017-2022)

Figure Japan Antianaphylaxis drugs Revenue (Million USD) and Growth Rate Forecast (2017-2022)

Figure Japan Antianaphylaxis drugs Price () Trend Forecast (2017-2022)

Figure Global Antianaphylaxis drugs Sales () and Growth Rate (%) Forecast (2017-2022)

Figure Global Antianaphylaxis drugs Revenue (Million USD) and Growth Rate Forecast (2017-2022)

Figure Global Antianaphylaxis drugs Price () Trend Forecast (2017-2022)

Table Japan Antianaphylaxis drugs Sales () Forecast by Type (2017-2022)

Table Global Antianaphylaxis drugs Sales () Forecast by Type (2017-2022)

Figure Japan Antianaphylaxis drugs Sales () Forecast by Type (2017-2022)

Figure Global Antianaphylaxis drugs Sales () Forecast by Type (2017-2022)

Figure Japan Antianaphylaxis drugs Sales Volume Market Share Forecast by Type in 2017

Figure Global Antianaphylaxis drugs Sales Volume Market Share Forecast by Type in 2017

Table Japan Antianaphylaxis drugs Sales () Forecast by Application (2017-2022)

Figure Japan Antianaphylaxis drugs Sales Volume Market Share Forecast by Application (2017-2022)

Figure Japan Antianaphylaxis drugs Sales Volume Market Share Forecast by Application in 2017

Table Global Antianaphylaxis drugs Sales () Forecast by Application (2017-2022)

Figure Global Antianaphylaxis drugs Sales Volume Market Share Forecast by Application (2017-2022)

Figure Global Antianaphylaxis drugs Sales Volume Market Share Forecast by Application in 2017

Table Japan Antianaphylaxis drugs Sales () Forecast by Regions (2017-2022)

Table Japan Antianaphylaxis drugs Sales Volume Share Forecast by Regions (2017-2022)

Figure Japan Antianaphylaxis drugs Sales Volume Share Forecast by Regions (2017-2022)

Table Global Antianaphylaxis drugs Sales () Forecast by Regions (2017-2022)

Table Global Antianaphylaxis drugs Sales Volume Share Forecast by Regions (2017-2022)

Figure Global Antianaphylaxis drugs Sales Volume Share Forecast by Regions (2017-2022)

Table Research Programs/Design for This Report

Figure Bottom-up and Top-down Approaches for This Report

Figure Data Triangulation

Table Key Data Information from Secondary Sources

Table Key Data Information from Primary Sources



Make an enquiry before buying this Report

Please fill the enquiry form below.

  • Full Name *
  • Your Email *
  • Job Title *
  • Company *
  • Phone No. * (Pls. Affix Country Code)
  • Message
  • Security Code *